1.
GULYAKIN I, LANTSOVA A, NIKOLAEVA L, DMITRIEVA M, OBOROTOVA N, ORLOVA O, ZHURAVLEVA N. FEATURES OF THE DEVELOPMENT OF A LYOPHILIZED INJECTABLE DOSAGE FORM OF THE ORIGINAL ANTICANCER DRUG LCS-1208. Int J App Pharm [Internet]. 2021 Jul. 7 [cited 2022 Jun. 30];13(4):102-5. Available from: https://innovareacademics.in/journals/index.php/ijap/article/view/41371